sians and is rare among people of African descent; KEL10 is observed in Finns (2.6%) and Japanese (0.46%), and KEL31 has only been reported in Japanese (1.5%) [2, [8] [9] [10] [11] .
The Kell glycoprotein (CD238) is a member of the neprilysin family of zinc endopeptidases, whose principal function is the activation of bioactive peptides by proteolytic cleavage of larger inactive polypeptides; however, the function of the Kell glycoprotein on RBCs is unknown [8, 9] . While this family of enzymes has distinct substrate specificity, there is an overlap in function, especially between Kell and endothelin-converting enzymes-1 and -2 (ECE-1 and ECE-2). Big endothelin-3 is the preferred substrate for Kell, being nearly 100 times more effective as a substrate than either big endothelin-1 or big endothelin-2. Nevertheless, Kell is also active in big endothelin-1 and big endothelin-2 [8, 12] . Conversely, ECE-1 and ECE-2 prefer big endothelin-1 as substrate but they can also cleave big endothelin-2 and big endothelin-3. As a group, the endothelins play many different physiological roles. Primarily they act in the blood pressure regulation by affecting contraction and proliferation of vascular smooth muscle and by their vasodilator effects via endothelin-mediated release of nitric oxide. The endothelins are also involved in mitogenesis and developmental process by affecting the differentiation and migration of neural crestderived cells. The role that Kell, as an endothelin-3-converting enzyme, plays in these processes and whether or not it has a complementary role with XK protein is still unknown [8, 9, 12] .
Kell protein is mainly present on red blood cells (RBCs) and testes, and in lesser amounts on brain tissue, lymphoid organs (spleen and tonsil), heart, skeletal muscles, and myeloid progenitor cells [10, 13, 14] . Two distinct proteins, Kell and XK, linked by a single disulfide bond, are responsible for the Kell blood group antigen expression. The XK protein spans the RBC membrane 10 times and expresses only one antigen, Kx. The KEL antigens are carried by Kell which is a 93-kDa type II membrane glycoprotein (CD238) with at least five N-glycosylation sites [2, [8] [9] [10] [2, 10] . The rare K 0 phenotype is defined by total absence of the Kell protein and all KEL antigens on RBCs and occurs by homozygosity or compound heterozygosity for silent alleles at the KEL locus. K 0 RBCs have normal discoid shape but a decreased amount of the XK protein is expressed even though Kx antigen expression appears elevated [2, 10] . Although K 0 persons have lost the enzyme active sites, a lack of Kell enzyme activity does not result in a recognizable illness. Compensatory mechanism may be activated in the K 0 phenotype, probably involving the overlapping functions of other neprilysin family enzymes [8, 9, 12] . K 0 persons, however, can produce anti-KEL5 (anti-Ku) antibody after transfusion and/or pregnancy which is associated to severe hemolytic transfusion reaction and perinatal anemia, requiring K 0 blood for transfusion [2, 10, 15, 16] . In contrast, the absence of the XK protein leads to the McLeod phenotype, which is associated with RBC acanthocytosis and late-onset neurologic defects, and with the depressed expression of Kell protein. McLeod persons can produce antibodies to Kx and Km antigens when alloimmunized [17] [18] [19] .
Although the K 0 phenotype has been known since 1957, the first reports of the K 0 molecular basis occurred only in 2001 [20] [21] [22] . At present, 37 K 0 alleles are recognized to abolish the KEL antigens expression, most of them due to stop codon and alternative splicing caused by single nucleotide mutation. These mutations have been detected in different populations reported by Asian, European and North American studies nevertheless none performed in Amerindian-Caucasian descendants from South America [5, 6, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . In this paper, we reported the IVS16 + 1g>a mutation (KEL*02N.31 allele) and the c.1042C>T mutation (KEL*02N.04 allele) in three Brazilian K 0 patients being descendants of Amerindian-Caucasians.
Material and Methods

Samples
The Recife K 0 patient was a 59-year-old woman of Amerindian-Caucasian descent from Northeast Brazil who showed an antibody that reacted against high-prevalence RBC antigens during a pre-transfusion evaluation for orthopedic surgery and was presumed to be anti-KEL5 (anti-Ku). She had prior history of blood transfusion in 2006. Blood samples in EDTA from the patient, her sister, and two nieces were also tested.
The Vila Velha K 0 case was an 86-year-old woman of Amerindian-Caucasian descent from Southeast Brazil who showed an antibody that reacted against high-prevalence RBC antigens during a pre-transfusion evaluation for orthopedic surgery and was presumed to be anti-KEL5 (anti-Ku). She had prior history of nine pregnancies, but none blood transfusion. Blood samples in EDTA from the patient, her sister, a son, and four grand-daughters were also tested.
The Manaus K 0 patient was a 44-year-old woman of Amerindian-Caucasian descent from Amazon region, North Brazil, suffering from severe anemia (hemoglobin = 3.0 g/dl) while receiving anti-tumor treatment. She presented an RBC alloantibody to a high-incidence antigen, which was presumed to be antiKu. She KEL Phenotyping by Serology K 0 status was identified by standard serologic techniques that included adsorption-elution at the blood centers that referred these samples. Confirmation and further serology were performed at the blood center of the Federal University of São Paulo using standard immunohematological methods, including the RBC alloantibody screening tests performed with two different RBCs panels (DIAMED Latino América, MG, Brazil, and ASEM-NPBI Produtos Hospitalares, SP, Brazil) before, and after treatment with papain, ZZAP (papain and DDT -dithiothreitol), and AET (2-aminoethylisothiouronium bromide) reagents.
KEL Genotyping and Sequencing
Genomic DNA was prepared from peripheral blood using commercial extraction kit (QIAamp DNA Blood mini kit; Qiagen, Hilden, Germany).
KEL genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) as previously described [31] [32] [33] .
To identify the molecular defect, we used sequencing technique covering all 19 coding and exon-intron regions of the KEL gene. 19 exons of the KEL gene were amplified into 15 segments using previously described methods [21] . The PCR products were separated by 2% agarose gel electrophoresis and purified using a commercial kit (GFX PCR DNA and Gel Band Purification Kit, GE Healthcare, Hatfield, UK). The purified PCR products were then sequenced using forward and reverse sequencing primers at ABI Prism 3100 Genetic Ana-lyser (Applied Biosystems, Life Technologies, Carlsbad, CA, USA). All sequences were analyzed with BioEdit software (Biological sequence alignment editor; Applied Biosystems, Life Technologies).
The c.1042C>T mutation was confirmed by a PCR-Tsp45I-RFLP analysis performed as previously described [20] . A 310-bp DNA fragment that includes exon 9 was amplified, and the PCR products from common Kell-type DNA and from DNA containing the c.1042C>T mutation were treated with Tsp45I restriction enzyme (New England Biolabs, Beverly, MA, USA). The C1042T mutation abolishes the Tsp-45I restriction site. To evaluate the interference of the freezing-thawing process on RBC surface antigen expression, fresh and thawed RBCs from controls 1 and 2 were tested by staining with anti-KEL reagents and PE-conjugated antihuman glycophorin. There were no significant differences with regard to KEL and glycophorin expressions between fresh and frozen samples. The g>a mutation on intron 16, position +1 downstream of exon 16, IVS16 + 1g>a mutation, (KEL*02N.31 allele) was identified by KEL sequencing technique at homozygous state on the Recife K 0 patient and at heterozygous state on her sister ( fig. 1) . No mutation was detected in the patient's two nieces.
KEL Antigen Phenotyping by Flow Cytometry
Results
Recife
To confirm the K 0 phenotype caused by IVS16 + 1g>a, we performed additional phenotyping tests using flow cytometry. The results of flow cytometry are summarized in table 2. Patient's RBCs were negative for all anti-KEL antibodies. In control 1, the expression was positive for CD238 (MFI = 77), KEL2 (MFI = 189.4) and KEL4 (MFI = 114.4) and negative for KEL1 and KEL3. In control 2, all antigens were positive, but KEL3 (MFI = 7.8) (fig. 2) to be in a homozygous mutant pattern (310-bp band) in the Vila Velha K 0 , while we identified the mutation in a heterozygous pattern (90-, 220-and 310-bp bands) in her sister and son. The wildtype pattern (90-and 220-bp bands) was observed in all four grand-daughters. The c.1042C>T mutation (KEL*02N.04 allele) was identified at homozygous state in exon 9 by KEL sequencing technique and confirmed using PCR-Tsp45I-RFLP.
Discussion
Kell is one of the most polymorphic blood group systems with 35 described antigens to date. All antigens result from missense single-nucleotide polymorphisms and subsequent single-amino acid substitutions, with the exception of Km and Ku which are likely to be broadly reactive with one or more epitopes on the Kell glycoprotein [2, 5] . The K 0 phenotype, characterized by total lack of the Kell protein and all KEL antigens on RBC surface, is a quite rare phenotype. Therefore, it is a real challenge to accurately measure the frequency of this phenotype even in populations with similar genetic background. Recent data reported that the K 0 frequency is expected to be 0.00228% in Chinese [26] and no more than 0.00017% in Austrian population [25] . These latest findings showed much lower frequencies than previously estimated in Europeans and Japanese of 0.007% and 0.008%, respectively [34] . Currently, 37 different K 0 alleles in a scarce number of individuals have been recognized to abolish the KEL antigen expression, most of them due to stop codon and alternative splicing caused by single nucleotide mutation. There are also a few examples of nucleotide insertion or deletion, and 7 cases of missense mutation [5, 6, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . Table 3 [5, 25, 27, 29] . Around 1-7% of all seemingly K+, k-individuals may be expected to carry an undetected and rudimentary expressed KEL*02 allele and, as a consequence, discordant phenotype/genotype results [25, 29] . Therefore, the clinical practice based on DNA analysis for blood group antigens requires caution, and the performance of the blood group phenotype prediction should be improved.
At present, there is no published data about K 0 molecular basis in Amerindian-Caucasians from South America. In this study, we have investigated K 0 samples from three non-related individuals and their available relatives to identify which K 0 alleles are found in the Brazilian highly mixted population, which is composed of Native Amerindians, people of African descent, and European Caucasian descendants mainly from Portugal, which was the colonizer of Brazil in the past. We have identified in this study the KEL*02N.04 allele, in which the c.1042C>T mutation generates a premature stop codon. Interestingly, this mutation was first reported by Lee et al. [21] as cause of the K 0 phenotype in a Portuguese Caucasian woman during her second pregnancy. The c.1042C>T mutation in exon 9 converts a CAA codon encoding glutamine, at position 348, to a TAA stop codon. The c.1042C>T mutation was also detected in an Austrian person who presented the K+, k-phenotype, but the KEL*01/02 genotype. The discrepancy between the phenotyping and genotyping results was elucidated by the presence of the c.1042C>T mutation in the KEL*02N allele [25] . In this study, we have detected the c.1042C>T mutation (KEL*02N.04 allele) in a homozygous state in two non-related Amerindian-Caucasian individuals (the Vila Velha K 0 and the Manaus K 0 patient), and also in a heterozygous state on sister and son of the Vila Velha's K 0 patient. Presently, KEL*02N.06 (IVS3 + 1g>a) is by far the most frequent KEL*02N allele, observed in at least 19 individuals from different areas around the world [25] . As a consequence of these new findings, KEL*02N.04 (c.1042C>T) has now became the second most frequent KEL*02N allele with at least 13 allele observations in 10 different persons -3 homozygous K 0 and 7 heterozygous individuals -from Europe and South America [21, 25] .
The second allele identified in this study was the KEL*02N.31 allele which has a splice site mutation (g>a) in the exon 16-intron 16 junction. The IVS16 + 1g>a mutation was identified at homozygous state on the Recife K 0 patient and at heterozygous state on her sister. This mutation, IVS16 + 1g>a, changes the conserved gt sequence and disrupts the 5 -splice site, introducing an alternative splicing. Based on evidence from KEL and other genes with 5 -splice site mutations at this position, it is expected that the exon 16 is skipped in the transcript maturation process [21, 27, 35] . The reading frame shift created by skipping the exon 16 probably introduces a downstream premature stop codon (TGA) on exon 17, or simply result in a shortened sequences that may either be unfavorable at the transcriptional or translational level. As previously described, this gene defect type may also express a truncated protein that is initially inserted into the endoplasmic reticulum membrane, but in no case there was any evidence of the presence of a truncated protein on the RBCs of the K 0 individuals, indicating that the truncated proteins are probably degraded intracellularly and are not transported to the RBC surface membrane [21, 27] . Most likely this splice mutation, IVS16 + 1g>a, is responsible for the absence of the KEL antigens normally encoded by KEL*02 allele as demonstrated by standard serology and flow-cytometric techniques. These interesting new scientific observations were first reported by our group and presented as an abstract at the 52nd ASH meeting in 2010 [36] . Recently, this IVS16 + 1g>a mutation was also detected in another Brazilian Caucasian female by other Brazilian investigators [37] .
In conclusion, in this study we describe the K 0 molecular basis in Amerindian-Caucasian descendents from South America. The c.1042C>T mutation (KEL*02N.04 allele) was identified in homozygous state causing the K 0 phenotype in two Brazilian patients and the IVS16 + 1g>a mutation (KEL*02N.31 allele) was defined in homozygous state in the 3rd K 0 patient. This last reported mutation has only been observed in Brazilians so far.
